A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions

Author(s):
Steenwijk, P.J.D. van; Ramwadhdoebe, T.H.; Lowik, M.J.G.; Minne, C.E. van der; Berends-van der Meer, D.M.A.; Fathers, L.M.; Valentijn, A.R.P.M.; Oostendorp, J.; Fleuren, G.J. (0000-0002-9276-183X); Hellebrekers, B.W.J.; Welters, M.J.P.; Poelgeest, M.I. van; Melief, C.J.M.; Kenter, G.G.; Burg, S.H. van der (0000-0002-6556-0354)
Published
2012
Publication type
Article / Letter to editor
HSILHPV16ImmunotherapyVaccination
Date issued
2012-09-30
Language
English
Is part of
Cancer Immunology, Immunotherapy (2012), Vol. 61, no. 9, p. 1485-1492
hdl
1887/88203
doi
10.1007/s00262-012-1292-7